TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NO PILL LEFT BEHIND

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

NO PILL LEFT BEHIND

ST13

US500000097277783

Class

35

Filing

97277783

Registration

7221275

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

11/21/2023

Classification

Registered

Trademark type

Word

Nice classes

35

Filing date

02/22/2022

Registration date

11/21/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/21/2023

Last transaction

11/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/24/2022

First use in commerce

01/24/2022

Drawing code

4

Owner type

16

Owner location

Nazareth, PA, US

Examiner

DEFORD, JEFFREY S

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Pharmabid, LLC

Representatives

Melissa E. Scott FOX ROTHSCHILD LLP

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

On-line retail store services featuring pharmaceuticals for licensed, pre-approved customers; Online auction services featuring pharmaceuticals for licensed, pre-approved bidders; Providing a website whereby licensed, pre-approved third party buyers of pharmaceutical goods and services locate and purchase product through either a fixed price or auction format from multiple competitive sellers of pharmaceutical goods or services

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/21/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

11/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/05/2023

PUBO

PUBLISHED FOR OPPOSITION

09/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/16/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/28/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/27/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/27/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/27/2023

ALIE

ASSIGNED TO LIE

07/27/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/21/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/12/2023

GNRT

NON-FINAL ACTION E-MAILED

03/12/2023

CNRT

NON-FINAL ACTION WRITTEN

03/12/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

03/12/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/12/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

03/12/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/12/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/28/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/28/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/28/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/07/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/07/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/07/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/07/2022

GNRT

NON-FINAL ACTION E-MAILED

12/07/2022

CNRT

NON-FINAL ACTION WRITTEN

12/07/2022

DOCK

ASSIGNED TO EXAMINER

12/06/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/28/2022

NWAP

NEW APPLICATION ENTERED

02/25/2022

Continuous trademark protection

Get notified about every new filing that threatens NO PILL LEFT BEHIND or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.